Categories: Wire Stories

Notice Regarding Planned Commencement of Tender Offer for Benesse Holdings, Inc. (Securities Code: 9783) by Bloom1 K.K.

TOKYO–(BUSINESS WIRE)–Bloom1 K.K. (the ‘”Offeror”), which is invested by Soichiro Fukutake and Hideaki Fukutake, founding family members of Benesse Holdings, Inc. (the “Target Company“), and an investment vehicle managed by EQT AB Group, a private equity investment firm based in Sweden (“EQT”), decided today to proceed with the tender offer for the Target Company (the tender offer price is expected to be 2,600 yen per share of the Target Company shares) (“Tender Offer”) after obtaining the Target Company’s support and recommendation to shareholders to tender their shares in the tender offer.


The commencement of the Tender Offer is expected to be in or around early February 2024, after obtaining necessary permits and approvals based on competition laws in Japan and China and the Foreign Exchange and Foreign Trade Acts in Japan.

After the completion of the Tender Offer, the Target Company will continue to provide its current businesses and services to its customers and is committed to delivering even better services.

For more details, please refer to the attached document titled “Notice Regarding Planned Commencement of Tender Offer for Benesse Holdings, Inc. (Securities Code: 9783)”.

1. Purpose and Background of the Tender Offer

The business environment surrounding the Target Company has become increasingly challenging. In order for the Target Company to become a global platform for “well-living” of all generations in the world in both the digital and the real world, as its “third business,” it is necessary to promote additional measures such as digitization of education business, reinforcement of overseas education business, and expansion of nursing care business through M&A.

In such an environment, Soichiro Fukutake and Hideaki Fukutake believed that, through privatization, distancing the Target Company from capital market, where financial results are expected to be achieved in every accounting period, and collaborating with an influential external partner to utilize their knowledge and experiences would be a viable option for accelerating a long-term and sustainable business transformation and growth of the Target Company and for realizing the “third business”. Under such circumstances, they received an offer in early December 2022 from EQT, which has extensive investment experience and knowledge in the education and nursing care fields, and after extensive discussions, they decided to proceed with the Tender Offer.

Soichiro Fukutake, Hideaki Fukutake, and EQT believe that, through the privatization of Target Company shares via a management buyout (MBO), the founding family and EQT can work together with the Target Company’s management team to steer the company as fellow shareholders having a shared vision to ensure the successful execution of the Transformation Business Plan that the Target Company has been pursuing, as well as to implement additional measures. This will not only ensure the Target Company’s mid- to long-term growth and enhance the quality of its education and nursing care services but also help the Target Company make returns for its business partners and employees.

2. Scheme of the Tender Offer

Soichiro Fukutake, Hideaki Fukutake, and EQT aim to privatize the shares of the Target Company through the tender Offer, followed by a squeeze-out and subsequent transactions.

Contacts

KRIK, Inc. (PR Agent)

Koshida: +81-070-8793-3990

Sugiyama: +81-070-8793-3989

Alex

Recent Posts

Verdantis Appoints Kumar Gaurav Gupta as Chief Executive Officer

PRINCETON, N.J.--(BUSINESS WIRE)--Verdantis, a pioneering leader in AI-powered data solutions, proudly announces the appointment of…

43 mins ago

Galaxy Macau, The World-class Luxury Integrated Resort Comes to the “Experience Macao Roadshow in Jakarta”

Providing Exclusive and Unique Experiences to Indonesian Tourists MACAU SAR - Media OutReach Newswire -…

45 mins ago

SK hynix and HLDS Jointly Developed Tube T31 and Haechi H02 Win Red Dot Design Award and Exhibit at COMPUTEX

SEOUL, South Korea--(BUSINESS WIRE)--Leading semiconductor company SK hynix today announced that its stick-type SSD, the…

2 hours ago

NADclinic and Bontac Bio-Engineering (Shenzhen) Co., Ltd Announce Strategic Partnership to Evolve the Future of Global Wellness Through the Power of NAD+

LONDON--(BUSINESS WIRE)--NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic…

2 hours ago

Drug Farm Announces IND Clearance by U.S. FDA Enabling Phase 1b Initiation for ALPK1 Selective Kinase Inhibitor, DF-003 in ROSAH Syndrome Patients

GUILFORD, Conn. & SHANGHAI--(BUSINESS WIRE)--Drug Farm announced today the U.S. Food and Drug Administration (FDA)…

2 hours ago

LiveSpo Pharma Emerges as Vietnam’s Pioneer at Vitafoods Europe 2024

Unveiling Groundbreaking Research and Product Development to Reduce Antibiotic Use in Digestive and Respiratory Care…

2 hours ago